Albrecht; Barbara
Patent Applications and Registrations
Patent applications and USPTO patent grants for Albrecht; Barbara.The latest application filed is for "heterocyclic derivatives".
- Albrecht; Barbara - Wulfrath N/A DE
- Albrecht; Barbara - Wuppertal DE
| Patent | Date |
|---|---|
| Substituted phenylaminothiazoles and use thereof Grant 8,691,850 - Erguden , et al. April 8, 2 | 2014-04-08 |
| Heterocyclic derivatives Grant 8,343,987 - Gielen-Haertwig , et al. January 1, 2 | 2013-01-01 |
| I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use Grant 8,173,665 - Gielen-Haertwig , et al. May 8, 2 | 2012-05-08 |
| 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors Grant 8,101,615 - Gielen-Haertwig , et al. January 24, 2 | 2012-01-24 |
| Dihydropyridinone derivatives Grant 8,097,629 - Gielen-Haertwig , et al. January 17, 2 | 2012-01-17 |
| Heterocyclic derivatives Grant 7,893,073 - Gielen-Haertwig , et al. February 22, 2 | 2011-02-22 |
| Substituted [(phenylethanoyl)amino]benzamides Grant 7,776,922 - Bruggemeier , et al. August 17, 2 | 2010-08-17 |
| Heterocyclic Derivatives App 20100184788 - GIELEN-HAERTWIG; Heike ; et al. | 2010-07-22 |
| Prss23 As A Biomarker, Therapeutic And Diagnostic Target App 20100104501 - Golz; Stefan ; et al. | 2010-04-29 |
| Dihydropyridine derivatives for use as human neutrophil elastase inhibitors Grant 7,691,854 - Gielen-Haertwig , et al. April 6, 2 | 2010-04-06 |
| Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes Grant 7,687,510 - Gielen-Haertwig , et al. March 30, 2 | 2010-03-30 |
| I-pheny 1-3,4-dihydropyrimidin-2(1h)-one Derivatives And Their Use App 20100022537 - Gielen-Haertwig; Heike ; et al. | 2010-01-28 |
| 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use Grant 7,566,723 - Gielen-Haertwig , et al. July 28, 2 | 2009-07-28 |
| Substituted Phenylaminothiazoles and Use Thereof App 20080269300 - Erguden; Jens-Kerim ; et al. | 2008-10-30 |
| Substituted [(Phenylethanoyl)Amino]Benzamides App 20080171786 - Bruggemeier; Ulf ; et al. | 2008-07-17 |
| 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors App 20080064704 - Gielen-Haertwig; Heike ; et al. | 2008-03-13 |
| Dihydropyridinone Derivatives App 20080045541 - Gielen-Haertwig; Heike ; et al. | 2008-02-21 |
| Heterocyclic Derivatives App 20080021053 - Gielen-Haertwig; Heike ; et al. | 2008-01-24 |
| Dihydropyridine derivatives for use as human neutrophil elastase inhibitors App 20070167406 - Gielen-Haertwig; Heike ; et al. | 2007-07-19 |
| Dihydropyridinone derivatives Grant 7,230,017 - Gielen-Haertwig , et al. June 12, 2 | 2007-06-12 |
| Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) Grant 7,125,995 - Albrecht , et al. October 24, 2 | 2006-10-24 |
| Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes App 20060160801 - Gielen-Haertwig; Heike ; et al. | 2006-07-20 |
| Heterocyclic derivatives App 20060111377 - Gielen-Haertwig; Heike ; et al. | 2006-05-25 |
| Dihydropyridinone derivatives App 20060100207 - Gielen-Haertwig; Heike ; et al. | 2006-05-11 |
| Substituted alkyl uracils and thereof App 20050159431 - Albrecht, Barbara ; et al. | 2005-07-21 |
| Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases App 20050075275 - Albrecht, Barbara ; et al. | 2005-04-07 |
| Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) App 20050075347 - Albrecht, Barbara ; et al. | 2005-04-07 |
| Substituted amidoalkyl-uracils and their use Grant 6,649,618 - Harter , et al. November 18, 2 | 2003-11-18 |
| Substituted amidoalkyl-uracils and their use App 20030022905 - Harter, Michael ; et al. | 2003-01-30 |
| NCAGE Code | 5LU41 | ALBRECHT BARBARA |
| CAGE Code | 5LU41 | ALBRECHT, BARBARA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 